FdaApplication
ANDA 206662
Identifiers
- fda_app_no: ANDA206662
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2020-11-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TACROLIMUS | TACROLIMUS | EQ 1MG BASE | CAPSULE;ORAL |
| TACROLIMUS | TACROLIMUS | EQ 0.5MG BASE | CAPSULE;ORAL |
| TACROLIMUS | TACROLIMUS | EQ 5MG BASE | CAPSULE;ORAL |
3 products